Lexaria Bioscience LEXX
NASDAQ LEXX
$2.82 -0.27 (-8.51%)
As of: Oct 2, 2026 · 1:57 PM EDT

Lexaria Bioscience (LEXX) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Lexaria Bioscience's Depreciation & Amortization (CF) came in at $19,208 for fiscal Q3 2026 (quarter ended May 31, 2026), down 37.9% from $30,955 a year earlier but up 0.6% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to May 31, 2026, Lexaria Bioscience reported Depreciation & Amortization (CF) of -$11,252; for FY2024 (ended Aug 31, 2024), it was $76,153, down 47.6% from FY2023.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 4.7% (FY2019 to FY2024).
  • Going back by fiscal year, Depreciation & Amortization (CF) was $145,397 in FY2023 (+41.5%), $102,718 in FY2022 (-8.1%), $111,718 in FY2021 (-0.9%) and $112,750 in FY2020 (+86.2%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is -$66,427 (fiscal Q4 2025) to $70,928 (fiscal Q4 2023).
  • Year-over-year, Depreciation & Amortization (CF) increased in three of the last seven quarters, with growth averaging 87.1%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in fiscal Q2 2026 (growth of 738.9%), and the weakest in fiscal Q2 2025 (a decline of 85.7%).
  • Business Quant data shows LEXX's Depreciation & Amortization (CF) at $19,101 (Q2 2026), $16,866 (Q1 2026) and -$66,427 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Lexaria Bioscience 3.26 Mn -12.39 Mn - 19,208.00
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 19,208.00
Feb 28, 2026 19,101.00
Nov 30, 2025 16,866.00
Aug 31, 2025 -66,427.00
May 31, 2025 30,955.00
Feb 28, 2025 2,277.00
Nov 30, 2024 33,195.00
Aug 31, 2024 16,370.00
May 31, 2024 15,074.00
Feb 29, 2024 15,931.00
Nov 30, 2023 28,778.00
Aug 31, 2023 70,928.00
May 31, 2023 25,010.00
Feb 28, 2023 24,729.00
Nov 30, 2022 24,730.00
Aug 31, 2022 24,732.00
May 31, 2022 23,893.00
Feb 28, 2022 26,163.00
Nov 30, 2021 27,930.00
Aug 31, 2021 27,930.00
API Access

Lexaria Bioscience Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LEXX&period=max&api_key=YOUR_API_KEY